EUVIMEDEUVIMED entdecken
Crossref

Selective inhibition of hepatitis B virus internalization by oxysterol derivatives

Mizuki Oshima, Frank Stappenbeck, Hirofumi Ohashi, Masashi Iwamoto, Kento Fukano, Atsuto Kusunoki, Xin Zheng, Feng Wang, Ryo Morishita, Hideki Aizaki, Ryosuke Suzuki, Masamichi Muramatsu und 4 weitere

Biochemical and Biophysical Research Communications · 2023-10 · 675 · 139-145

DOI: 10.1016/j.bbrc.2023.07.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-10. Verfasst von Mizuki Oshima und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Department of Applied Biological Sciences, Tokyo Univer…. Hauptthemen laut MEDLINE: Hepatitis B, Symporters. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Foundation for Applied Enzymology, AMED.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Given that the current approved anti-hepatitis B virus (HBV) drugs suppress virus replication and improve hepatitis but cannot eliminate HBV from infected patients, new anti-HBV agents with different mode of action are urgently needed. In this study, we identified a semi-synthetic oxysterol, Oxy185, that can prevent HBV infection in a HepG2-based cell line and primary human hepatocytes. Mechanistically, Oxy185 inhibited the internalization of HBV into cells without affecting virus attachment or replication. We also found that Oxy185 interacted with an HBV entry receptor, sodium taurocholate cotransporting polypeptide (NTCP), and inhibited the oligomerization of NTCP to reduce the efficiency of HBV internalization. Consistent with this mechanism, Oxy185 also inhibited the hepatitis D virus infection, which relies on NTCP-dependent internalization, but not hepatitis A virus infection, and displayed pan-genotypic anti-HBV activity. Following oral administration in mice, Oxy185 showed sustained accumulation in the livers of the mice, along with a favorable liver-to-plasma ratio. Thus, Oxy185 is expected to serve as a useful tool compound in proof-of-principle studies for HBV entry inhibitors with this novel mode of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis BSymportersHumansMiceAnimalsHepatitis B virusVirus InternalizationHepatocytesHep G2 CellsHepatitis Delta VirusOrganic Anion Transporters, Sodium-Dependent

Stichwörter der Autor:innen

AntiviralEntryHBVHDVNTCPOxysterol

Substanzen

SymportersOrganic Anion Transporters, Sodium-Dependent

Autor:innen und Institutionen

  • Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Department of Applied Biological Sciences, Tokyo University of Science, Noda, 278-8510, Japan.
  • MAX BioPharma, Inc., Santa Monica, CA, 90404, USA.
  • Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
  • Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
  • Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
  • CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Foundation for Applied Enzymology
  • AMED
  • Takeda Science Foundation
  • Japan Science and Technology Agency

Zitieren

APA

Oshima, M., Stappenbeck, F., Ohashi, H., Iwamoto, M., Fukano, K., Kusunoki, A., Zheng, X., Wang, F., Morishita, R., Aizaki, H., Suzuki, R., Muramatsu, M., Kuramochi, K., Sureau, C., Parhami, F., & Watashi, K. (2023). Selective inhibition of hepatitis B virus internalization by oxysterol derivatives. Biochemical and Biophysical Research Communications, 675, 139-145. https://doi.org/10.1016/j.bbrc.2023.07.014

Vancouver

Oshima M, Stappenbeck F, Ohashi H, Iwamoto M, Fukano K, Kusunoki A, et al. Selective inhibition of hepatitis B virus internalization by oxysterol derivatives. Biochemical and Biophysical Research Communications. 2023;675:139-145. doi:10.1016/j.bbrc.2023.07.014

BibTeX
@article{Oshima2023,
  author = {Oshima, Mizuki and Stappenbeck, Frank and Ohashi, Hirofumi and Iwamoto, Masashi and Fukano, Kento and Kusunoki, Atsuto and Zheng, Xin and Wang, Feng and Morishita, Ryo and Aizaki, Hideki and Suzuki, Ryosuke and Muramatsu, Masamichi and Kuramochi, Kouji and Sureau, Camille and Parhami, Farhad and Watashi, Koichi},
  title = {Selective inhibition of hepatitis B virus internalization by oxysterol derivatives},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {675},
  pages = {139--145},
  doi = {10.1016/j.bbrc.2023.07.014}
}
Kostenlos starten →